[Effect of hormonal therapy on plasma FSH, LH and testosterone levels in prostatic cancer].
作者信息
Shirai M, Matsuda S, Mitsukawa S, Nakamura M, Yonezawa K
出版信息
Nihon Hinyokika Gakkai Zasshi. 1975 Feb;66(2):59-67. doi: 10.5980/jpnjurol1928.66.2_59.
PMID:1168823
Abstract
摘要
相似文献
1
[Effect of hormonal therapy on plasma FSH, LH and testosterone levels in prostatic cancer].
Nihon Hinyokika Gakkai Zasshi. 1975 Feb;66(2):59-67. doi: 10.5980/jpnjurol1928.66.2_59.
2
[Value of testosterone, FSH and LH on plasma in patients with prostatic adenoma and carcinoma before and after different hormonal treatments].
Rev Clin Esp. 1978 Jan 15;148(1):19-23.
3
Effects of oestrogen treatment on serum gonadotrophin bioactivity, immunoreactivity and isohormone distribution, and on immunoreactive inhibin levels, in prostatic cancer patients.
Clin Endocrinol (Oxf). 1994 Jun;40(6):743-50. doi: 10.1111/j.1365-2265.1994.tb02507.x.
4
Changes in plasma levels of FSH, LH and testosterone during anti-androgenic hormone therapy for patients with prostatic cancer.
Tohoku J Exp Med. 1974 Oct;114(2):145-58. doi: 10.1620/tjem.114.145.
5
[Significance of serum testosterone and LH determination in the hormonal therapy of prostatic cancer].
Rozhl Chir. 1978 Dec;57(12):805-12.
6
Plasma steroid and protein hormone concentrations in patients with prostatic carcinoma, before and during oestrogen therapy.
Acta Endocrinol (Copenh). 1976 Feb;81(2):409-26. doi: 10.1530/acta.0.0810409.
7
Testicular endocrine function after withdrawal of oestrogen treatment in patients with carcinoma of the prostate.
Br J Urol. 1983 Feb;55(1):42-7. doi: 10.1111/j.1464-410x.1983.tb07077.x.
8
[Plasma testosterone: a sound criterion of the effectiveness of hormonal treatment of prostatic carcinoma].
Vutr Boles. 1980;19(3):42-6.
9
10
Percutaneous 17 beta-estradiol in treatment of cancer of prostate.
Urology. 1979 Oct;14(4):373-5. doi: 10.1016/0090-4295(79)90083-9.
Zotero 插件